In addition, increased PSMA uptake on PSMA-ligand PET/CT has been indicated to be positively correlates with prostate cancer aggressiveness and adverse pathologic features in our previous studies (13, 14), making PSMA-ligand PET/CT a potential tool to predict BCR following RP. The gene discussed is FOLH1; the disease is Familial prostate cancer.